| Literature DB >> 27994554 |
Michael J Davies1, Bradley Clark2, Marijke Welvaert1, Sabrina Skorski3, Laura A Garvican-Lewis4, Philo Saunders5, Kevin G Thompson2.
Abstract
In search of their optimal performance athletes will alter their pacing strategy according to intrinsic and extrinsic physiological, psychological and environmental factors. However, the effect of some of these variables on pacing and exercise performance remains somewhat unclear. Therefore, the aim of this meta-analysis was to provide an overview as to how manipulation of different extrinsic factors affects pacing strategy and exercise performance. Only self-paced exercise studies that provided control and intervention group(s), reported trial variance for power output, disclosed the type of feedback received or withheld, and where time-trial power output data could be segmented into start, middle and end sections; were included in the meta-analysis. Studies with similar themes were grouped together to determine the mean difference (MD) with 95% confidence intervals (CIs) between control and intervention trials for: hypoxia, hyperoxia, heat-stress, pre-cooling, and various forms of feedback. A total of 26 studies with cycling as the exercise modality were included in the meta-analysis. Of these, four studies manipulated oxygen availability, eleven manipulated heat-stress, four implemented pre-cooling interventions and seven studies manipulated various forms of feedback. Mean power output (MPO) was significantly reduced in the middle and end sections (p < 0.05), but not the start section of hypoxia and heat-stress trials compared to the control trials. In contrast, there was no significant change in trial or section MPO for hyperoxic or pre-cooling conditions compared to the control condition (p > 0.05). Negative feedback improved overall trial MPO and MPO in the middle section of trials (p < 0.05), while informed feedback improved overall trial MPO (p < 0.05). However, positive, neutral and no feedback had no significant effect on overall trial or section MPO (p > 0.05). The available data suggests exercise regulation in hypoxia and heat-stress is delayed in the start section of trials, before significant reductions in MPO occur in the middle and end of the trial. Additionally, negative feedback involving performance deception may afford an upward shift in MPO in the middle section of the trial improving overall performance. Finally, performance improvements can be retained when participants are informed of the deception.Entities:
Keywords: cycling; deception; feedback; heat-stress; hyperoxia; hypoxia; pacing; pre-cooling
Year: 2016 PMID: 27994554 PMCID: PMC5136559 DOI: 10.3389/fphys.2016.00591
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Flow chart summary of the study selection process.
Overview of the analyzed studies.
| Amann et al., | Crossover | 8 Well-trained male cyclists (63.3 ± 1.3 ml kg−1min−1) | 5 km cycling time-trial | Time-trial in normoxia (FiO2 = 0.21; CON.), hypoxia (FiO2 = 0.15; INTER), iso-oxia (FiO2 = 0.24–0.30; INTER) and hyperoxia (FiO2 = 1.00; INTER) | Exposure 3 min before trial, after a warm-up in normoxia | FiO2: 0.21 = 458 ± 7 s FiO2: 0.15 = 483 ± 8 s FiO2: 0.24–0.30 = 351 ± 7 s FiO2: 1.00 = 439 ± 7 s | 9 |
| Clark et al., | Crossover | 10 Well-trained male cyclists and triathletes (67.7 ± 1.3 ml kg−1min−1) | 5 min cycling time-trial | Time-trial in normoxia (FiO2 = 0.21; CON) and hypoxia (FiO2 = 0.19; 0.16; and 0.14 INTER) | Exposure before, during and after warm-up. Total of 40 min in hypoxia before trial | FiO2: 0.21 = 367 ± 42 MPO FiO2: 0.19 = 346 ± 41 MPO FiO2: 0.16 = 329 ± 38 MPO FiO2: 0.14 = 294 ± 37 MPO | 10 |
| Périard and Racinais, | Crossover | 12 Well-trained male cyclists | Cycling time-trial to complete 750 kJ | Time-trial in normoxia (FiO2 = 0.21; CON) and hypoxia (FiO2 = 0.15; INTER) | Exposure 5 min before trial, after a warm-up in normoxia | FiO2: 0.21 = 48.2 ± 5.7 min FiO2: 0.15 = 60.1 ± 6.5 min | 9 |
| Tucker et al., | Crossover | 11 Well-trained male cyclists (395 ± 33 PPO) | 20 km cycling time-trial | Time-trial in normoxia (FiO2 = 0.21; CON) and hyperoxia (FiO2 = 0.40; INTER) | Time point unknown, including oxygen inhaled in warm-up | FiO2: 0.21 = 28 ± 8 min FiO2: 0.40 = 27 ± 34 min | 9 |
| Abbiss et al., | Crossover | 10 Well-trained male cyclists (61.7 ± 5.0 ml kg−1min−1) | 16.1 km cycling time-trial | Time-trial in temperate (18.1°C, 58% RH; CON) and heat (32°C, 50% RH; INTER) | Exposure during warm-up (90 min fixed workload) and at rest. Total of 116.3 min in heat before trial | 18.1°C = 25.4 ± 1.6 min 32°C = 27.5 ± 1.9 min | 8 |
| Altareki et al., | Crossover | 9 Competitive male triathletes and cyclists (61.7 ± 8.6 ml kg−1min−1) | 4 km cycling time-trial | Time-trial in cool (13°C, 40%; CON) and heat (35°C, 60% RH; INTER) | Exposure before, during and after warm-up. Total of 21 min in heat before trial | 13°C = 382.8 ± 18.2 s 35°C = 390.1 ± 19.6 s | 8 |
| Castle et al., | Crossover | 7 Recreational male cyclists (58.8 ± 5.7 ml kg−1min−1) | 30 min cycling time-trial | Time-trial in temperate (22°C, 43% RH; CON) and heat (31°C, 64% RH; INTER) | Exposure during a 7 min warm-up in heat before trial | 22°C = 179.9 ± 50.9 MPO 31°C = 168.1 ± 54.1 MPO | 9 |
| Peiffer and Abbiss, | Crossover | 9 Trained male cyclists (60.5 ± 4.5 ml kg−1min−1) | 40 km cycling time-trial | Time-trial in temperate (22°C, 40% RH; CON), cool (17°C, 40% RH; INTER), warm (27°C 40% RH; INTER), and hot (32°C, 40% RH; INTER) | Time point unknown, including temperature in warm-up | 17°C = 58.8 ± 2.0 min 22°C = 59.0 ± 2.3 min 27°C = 59.1 ± 2.3 min 32°C = 60.7 ± 2.9 min | 8 |
| Périard et al., | Crossover | 8 Well-trained male cyclists (66.4 ± 5.3 ml kg−1min−1) | 40 km cycling time-trial | Time-trial in temperate (20°C, 40%: CON) and heat (35°C, 60% RH; INTER) | Exposure 5 min before trial, after a warm-up in temperate | 20°C = 59.8 ± 2.6 min 35°C = 64.3 ± 2.8 min | 8 |
| Périard and Racinais, | Crossover | 11 Well-trained cyclists, 10 males and 1 female (60.2 ± 6.3 ml kg−1min−1) | Cycling time-trial to 750 kJ complete | Time-trial in temperate (20°C, 40%; CON) and heat (35°C, 60% RH; INTER) | Exposure 5 min before trial, after a warm-up in temperate | 20°C = 48.8 ± 12.7 min 35°C = 55.8 ± 14.4 min | 8 |
| Périard and Racinais, | Crossover | 12 Well-trained male cyclists | Cycling time-trial to 750 kJ complete | Time-trial in temperate (18°C, 40%; CON) and heat (35°C, 60% RH; INTER) | Exposure 5 min before trial, after a warm-up in temperate | 18°C = 48.2 ± 5.7 min 35°C = 55.4 ± 5.0 min | 8 |
| Schmit et al., | Parallel group | 34 Well-trained triathletes, gender unknown. Temperate ( | 20 km cycling time-trial | Time-trial in temperate (21°C, 50%; CON) acute heat exposure (35°C, 50% RH at 0; INTER and 11 ± 4 days; INTER) | Exposure 15 min before trial during a warm-up, the second heat trail took place 11 ± 4 days after trial 1 with no acclimatization | 7 | |
| Tatterson et al., | Crossover | 11 National male road cyclists (66.7 ± 13.6) | 30 min cycling time-trial | Time-trial in temperate (23°C, 60% RH; CON) and heat (32°C, 60% RH; INTER) | Time point unknown, including temperature in warm-up | 23°C = 345 ± 9 MPO 32°C = 323 ± 8 MPO | 8 |
| Tucker et al., | Crossover | 10 Recreational male cyclists (376 ± 47 PPO) | 20 km cycling time-trial | Time-trial in cool (15°C, 60% RH; CON) and heat (35°C, 60% RH; INTER) | Time point unknown, including temperature in warm-up | 15°C = 28.8 ± 1.8 min 35°C = 29.6 ± 1.9 min | 8 |
| VanHaitsma et al., | Crossover | 20 Trained male cyclists (54.8 ± 5.9) | 40 km cycling time-trial | Time-trial in temperate (21°C, 20% RH; CON) and heat (35°C, 25% RH; INTER) | Time point unknown, including temperature in warm-up | 21°C = 75.2 ± 6.6 min 35°C = 79.0 ± 7.2 min | 8 |
| Barwood et al., | Crossover | 11 Trained male cyclists | 40 km cycling time-trial | Time-trial in heat (32°C, 53% RH) with use of no spray (CON), menthol spray (INTER) and placebo cooling spray (INTER) | 10 min warm-up in heat, existed chamber (5 min rest in ~22°C), re-entered and sprayed with solution. Total of ~23 min in heat | CON = 71.58 ± 62 min Placebo = 70.94 ± 6.1 min Menthol = 71.04 ± 5.5 min | 9 |
| Byrne et al., | Crossover | 7 Recreational male cyclists | 30 min cycling time-trial | Time-trial in the heat (32°C, 60% RH) ingesting 900mL of hot (37°C; CON) or cold fluid (2°C; INTER) 10 min before trial | After fluid ingestion, 5 min at rest in heat, temperature of warm-up unknown | 37°C fluid = 261 ± 22 MPO 2°C fluid = 275 ± 27 MPO | 8 |
| Duffield et al., | Crossover | 8 Moderate to well-trained male cyclists (lactate threshold 221 ± 42 W) | 40 min cycling time-trial | Time-trial in the heat (33°C, 50% RH) with (INTER) and without (CON) lower body cold water immersion (CWI) at 14°C before trial | 20 min of CWI, 5 min warm-up in heat. Time between CWI and warm up ~8–10 min, ≤ 5 min from warm-up and trial start | CON = 178 ± 26 MPO 14°C CWI = 198 ± 25 MPO | 8 |
| Gonzales et al., | Crossover | 10 trained male cyclists (59.1 ± 7.0 ml kg−1min−1) | 20 min cycling time-trial | Time-trial in the heat (30°C, 79% RH) with (INTER) and without (CON) a cooling vest worn and refrigerated headband | 18 min warm-up with cooling vest and headband in heat. Rested in heat for 10 min (no vest) before trial. Total of 28 min in heat | CON = 222 ± 47 MPO Cooling vest = 239 ± 45 MPO | 8 |
| Albertus et al., | Crossover | 15 Competitive male cyclists (397 ± 58 PPO) | 20 km cycling time-trial | Time-trial with correct fb (CON) and positive deception (Pos-fb; INTER) | Informed traveled 25-m further than they had every km | CON = 28.4 ± 1.6 min Pos-fb = 28.6 ± 1.5 min | 8 |
| Castle et al., | Crossover | 7 Recreational male cyclists (58.8 ± 5.7 ml kg−1min−1) | 30 min cycling time-trial | Time-trial in the heat without deception (31°C, 64% RH; CON) and with deception (told the temperature was 26°C, 60% RH, reality: 32°C, 65% RH; Pos-fb; INTER) | From the onset of the trial and displayed incorrectly during trial on a computer screen | CON = 179.9 ± 50.9 MPO Pos-fb = 184.4 ± 60.4 MPO | 9 |
| Jones et al., | Parallel group | 20 Trained male cyclists, CON ( | 16.1 km cycling time-trial | Time-trial with accurate ride-alone fb (CON), against a pacer representing MPO of CON (Neutr-fb; INTER), unaware of MPO of pacer 102% above baseline (Neg-fb; INTER) and a subsequent ride-alone trial (not informed of deception in previous trial and not included in meta-analysis) | From the onset of the trial | 9 | |
| Jones et al., | Parallel group | 17 Trained male cyclists, CON ( | 16.1 km cycling time-trial | Time-trial with accurate ride-alone fb (CON), against a pacer representing MPO of CON (Neutr-fb; INTER), unaware or aware that MPO of pacer was increased 102% above (Neg-fb; INTER) and a subsequent ride-alone trial after being informed of the nature of a previous trial (Inform-fb; INTER) | From the onset of the trial | 9 | |
| Shei et al., | Crossover | 14 Competitive male cyclists (61.6 ± 0.6 ml kg−1min−1) | 4 km cycling time-trial | Time-trial with correct fb ride-alone (CON), unaware of MPO of pacer 102% above baseline (Neg-fb; INTER) and a subsequent trial after deception was revealed with known pacer at 102% (Inform-fb; INTER) | From the onset of the trial | CON = 366.4 ± 3.6 MPO Neg-fb = 358.6 ± 2.7 MPO Inform-fb = 358.1 ± 2.8 MPO | 8 |
| Smits et al., | Parallel group | 20 Trained male cyclists and triathletes, CON ( | 20 km cycling time-trial | Time-trial with distance only fb (CON) and no fb (No-fb; INTER) | From the onset of the trial, cyclists stopped at completed distance | CON = 28.7 ± 3.7 min No-fb = 31.0 ± 2.8 min | 8 |
| Swart et al., | Crossover | 12 Competitive cyclists (56.6 ± 6.6 ml kg−1min−1) | 40 km cycling time-trial | Time-trial with distance only fb (CON) and no fb (No-fb; INTER) | From the onset of the trial, at final km, cyclists were then informed they had 1-km to complete | CON = 265.5 ± 36.4 MPO No-fb = 256.6 ± 36.6 MPO | 8 |
| Waldron et al., | Crossover | 9 Well-trained male cyclists (60.5 ± 3.3 ml kg−1min−1) | 4 km cycling time-trial | Time-trial with correct ascending fb (CON) and increased ascending fb by 102% compared to CON (Pos-fb; INTER) | An ascending distance clock was continuously displayed and visible to participants | CON = 354 ± 39 s Pos-fb = 372 ± 36 s | 9 |
| Williams et al., | Parallel group | 22 Non-competitive and untrained males in cycling, CON ( | 4 km cycling time-trial | Time-trial with distance only fb (CON) and no fb (No-fb; INTER) | From the onset of the trial, cyclists stopped at completed distance | 9 | |
Data for VO.
Figure 2Number of studies meeting individual PEDro [Physiotherapy Evidence Database] criteria.
Figure 3Forest plot for hypoxia meta-analysis illustrating power output during start, middle and end sections compared to normoxia trials. Squares represent individual study mean difference and the lines represent 95% CIs. The size of the square is proportional to the weight of the study within the meta-analysis. The diamond represents the overall mean difference for each split with the width of the diamond signifying the 95% CIs.
Figure 4Forest plot for hyperoxia meta-analysis illustrating power output during start, middle and end sections compared to normoxia trials. Squares represent individual study mean difference and the lines represent 95% CIs. The size of the square is proportional to the weight of the study within the meta-analysis. The diamond represents the overall mean difference for each split with the width of the diamond signifying the 95% CIs.
Figure 5Forest plot for heat-stress meta-analysis illustrating power output during start, middle and end sections compared to temperate trials. Squares represent individual study mean difference and the lines represent 95% CIs. The size of the square is proportional to the weight of the study within the meta-analysis. The diamond represents the overall mean difference for each split with the width of the diamond signifying the 95% CIs.
Figure 6Forest plot for pre-cooling intervention meta-analysis illustrating power output during start, middle and end sections power output for start, middle and end sections compared to no intervention. Squares represent individual study mean difference and the lines represent 95% CIs. The size of the square is proportional to the weight of the study within the meta-analysis. The diamond represents the overall mean difference for each split with the width of the diamond signifying the 95% CIs.
Figure 7Forest plot for positive deceptive feedback meta-analysis illustrating power output during start, middle and end sections power output for start, middle and end sections compared to full feedback. Squares represent individual study mean difference and the lines represent 95% CIs. The size of the square is proportional to the weight of the study within the meta-analysis. The diamond represents the overall mean difference for each split with the width of the diamond signifying the 95% CIs.
Figure 8Forest plot for negative deceptive feedback meta-analysis illustrating power output during start, middle and end sections compared to full feedback. Squares represent individual study mean difference and the lines represent 95% CIs. The size of the square is proportional to the weight of the study within the meta-analysis. The diamond represents the overall mean difference for each split with the width of the diamond signifying the 95% CIs.
Figure 9Forest plot for neutral feedback meta-analysis illustrating power output during start, middle and end sections compared to full feedback. Squares represent individual study mean difference and the lines represent 95% CIs. The size of the square is proportional to the weight of the study within the meta-analysis. The diamond represents the overall mean difference for each split with the width of the diamond signifying the 95% CIs.
Figure 12Exploratory graphical analysis of the pacing index change score difference between control and hypoxic condition (A) and control and heat-stress condition (B) for each individual segment. For an explanation of how the pacing index change score was calculated please refer to section Data analysis of the Methods.
Figure 10Forest plot for no feedback meta-analysis illustrating power output during start, middle and end sections compared to full feedback. Squares represent individual study mean difference and the lines represent 95% CIs. The size of the square is proportional to the weight of the study within the meta-analysis. The diamond represents the overall mean difference for each split with the width of the diamond signifying the 95% CIs.
Figure 11Forest plot for informed feedback meta-analysis illustrating power output during start, middle and end sections compared to full feedback. Squares represent individual study mean difference and the lines represent 95% CIs. The size of the square is proportional to the weight of the study within the meta-analysis. The diamond represents the overall mean difference for each split with the width of the diamond signifying the 95% CIs.